Published June 29, 2020
| Version v9
Working paper
Open
Ivermectin for Covid-19
Description
Discussion of scholar papers published until June 29, 2020, on Ivermectin, and of news that we can find about its use for Covid-19. A list of clinical trials is also given. For what concerns scholar papers, we report among them a preprint posted on 10 June in MedRχiv, which concludes that Ivermectin was associated with lower mortality during treatment of Covid-19. From news, we consider in particular the case of Iquitos, capital city of the Loreto Region in Peru, where, by May 25, Covid-19 cases and deaths had dropped notably. The formulation of ivermectin used in Peru is also discussed, in particular that of the oral solution disclosed by the Peruvian Government.
Notes
Before reading this work, please consider that I am not a physician. I do not suggest the use of ivermectin. I am not touting this drug. This analysis of publications and news about ivermectin is made in the framework of a wider investigation about information concerning drugs used for Covid-19.
Files
Ivermectin-8.pdf
Files
(248.8 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:878440e8be7616aee58e19cc198bb4f8
|
248.8 kB | Preview Download |